NRXN1 and breast carcinoma: Breast cancer cases with positive menopausal status showed higher NRXN-1 mRNA expression (13.01-fold) compared to cases that do not have menopausal status (8.78-fold) and the expression differences among them was found to be statistically significant (p=0.03).